Is ZLDAF or NOBL a better dividend investment in 2026?

ZLDAF currently yields 609.16% with a 5% 5-year dividend growth rate. NOBL yields 4.00% with 5% growth. The better choice depends on your goal: ZLDAF offers higher current income.

What is the dividend yield difference between ZLDAF and NOBL?

ZLDAF has a forward dividend yield of 609.16% ($2.00/share annually). NOBL yields 4.00% ($2.00/share annually). The yield gap is 605.16 percentage points.

Home › Compare › ZLDAF vs NOBL

ZLDAF vs NOBL: Dividend Comparison 2026

ZLDAF yields 609.16% · NOBL yields 4.00%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 ZLDAF wins by $292137.29M in total portfolio value

INVESTMENT

TIME HORIZON10 years

ZLDAF

● Live price

609.16%

Share price

$0.33

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$292137.32M

Annual income

$220,826,387,190.95

Full ZLDAF calculator →

NOBL

● Live price

4.00%

Share price

$50.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$28.0K

Annual income

$899.19

Full NOBL calculator →

Portfolio growth — ZLDAF vs NOBL

📍 ZLDAF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	ZLDAF	NOBL
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, ZLDAF + NOBL cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

ZLDAF pays

NOBL pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ZLDAF

Annual income on $10K today (after 15% tax)

$51,778.75/yr

After 10yr DRIP, annual income (after tax)

$187,702,429,112.31/yr

NOBL

Annual income on $10K today (after 15% tax)

$340.00/yr

After 10yr DRIP, annual income (after tax)

$764.31/yr

At 15% tax rate, ZLDAF beats the other by $187,702,428,348.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ZLDAF + NOBL for your $10,000?

ZLDAF: 50%NOBL: 50%

100% NOBL50/50100% ZLDAF

Portfolio after 10yr

$146068.67M

Annual income

$110,413,194,045.07/yr

Blended yield

75.59%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ZLDAF buys

NOBL buys

No recent congressional trades found for ZLDAF or NOBL in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricZLDAFNOBL

Forward yield	609.16% ✓	4.00%
Annual dividend / share	$2.00	$2.00
Payout ratio	50%	50%
1-year div growth	0%	5% ✓
5-year div CAGR	0%	5% ✓
Portfolio after 10y	$292137.32M ✓	$28.0K
Annual income after 10y	$220,826,387,190.95 ✓	$899.19
Total dividends collected	$286203.91M ✓	$6.4K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: ZLDAF vs NOBL ($10,000, DRIP)

Year	ZLDAF Portfolio	ZLDAF Income/yr	NOBL Portfolio	NOBL Income/yr	Gap
1← crossover	$71,616	$60,916.18	$11,120	$420.00	+$60.5K → ZLDAF
2	$484,347	$407,718.13	$12,357	$458.31	+$472.0K → ZLDAF
3	$3,095,297	$2,577,045.67	$13,721	$499.76	+$3.08M → ZLDAF
4	$18,703,566	$15,391,597.96	$15,227	$544.58	+$18.69M → ZLDAF
5	$106,933,266	$86,920,450.25	$16,885	$593.02	+$106.92M → ZLDAF
6	$578,855,369	$464,436,774.20	$18,713	$645.34	+$578.84M → ZLDAF
7	$2,969,008,370	$2,349,633,124.95	$20,724	$701.81	+$2968.99M → ZLDAF
8	$14,439,931,036	$11,263,092,080.14	$22,938	$762.73	+$14439.91M → ZLDAF
9	$66,645,727,013	$51,195,000,804.51	$25,372	$828.41	+$66645.70M → ZLDAF
10	$292,137,315,095	$220,826,387,190.95	$28,047	$899.19	+$292137.29M → ZLDAF

ZLDAF vs NOBL: Complete Analysis 2026

ZLDAF — Stock

Zelira Therapeutics Limited, a bio-pharmaceutical company, engages in the research, development, and commercialisation of cannabinoid-based medicines for the treatment of various medical conditions in Australia. It offers formulations under the HOPE brand in Pennsylvania and Louisiana, as well as develops Zenivol, a cannabinoid-based medicine for treatment of chronic insomnia. The company also provides OTC products, including SprinJene, an oral care product; and RAF FIVE, a dermatology product, as well as ITURA, an advanced relief cream formula that targets multi-symptoms, such as numbness and tingling, muscle cramps, insensitivities, and pain associated with Peripheral Artery Disease and diabetes. Zelira Therapeutics has strategic partnerships with Curtin University; the Telethon Kids Institute; the University of Western Australia; St. Vincent's Hospital; and the Children's Hospital of Philadelphia. The company was formerly known as Zelda Therapeutics Limited and changed its name to Zelira Therapeutics Limited in December 2019. Zelira Therapeutics Limited was incorporated in 2003 and is headquartered in Perth, Australia.

Full ZLDAF Calculator →

NOBL — ETF

NOBL is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in NOBL shares.

Full NOBL Calculator →

📬

Get this ZLDAF vs NOBL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ZLDAF vs SCHD ZLDAF vs JEPI ZLDAF vs O ZLDAF vs KO ZLDAF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.